Skip to Main Content

Paper Details

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration.
J Antimicrob Chemother
1
2023
CKD, CLCR, Creatinine, HIV, P-glycoprotein, PLWH, Tenofovir, Tenofovir alafenamide, chronic kidney disease, patients, people, target cells, tenofovir, tenofovir alafenamide, tenofovir disoproxil fumarate
Author NameAffiliation
Matthias CavassiniLausanne University Hospital and University of Lausanne
Matthias CavassiniLausanne University Hospital and University of Lausanne
  • 1 - 2

Datasets

Release 1.2